List of Tables
Table 1. Global Antifungal Drug Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Antifungal Drug Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Antifungal Drug Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. Global Key Antifungal Drug Manufacturers Covered in This Study
Table 5. Global Antifungal Drug Sales (K Units) by Manufacturers (2015-2020)
Table 6. Global Antifungal Drug Sales Share by Manufacturers (2015-2020)
Table 7. Global Antifungal Drug Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Antifungal Drug Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Antifungal Drug Average Price (USD/Unit) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Antifungal Drug Sales Sites and Area Served
Table 11. Manufacturers Antifungal Drug Product Types
Table 12. Global Antifungal Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Antifungal Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antifungal Drug as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Antifungal Drug Players
Table 16. Global Antifungal Drug Sales (K Units) by Region (2015-2020)
Table 17. Global Antifungal Drug Sales Market Share by Region (2015-2020)
Table 18. Global Antifungal Drug Revenue (Million US$) by Region (2015-2020)
Table 19. Global Antifungal Drug Revenue Market Share by Region (2015-2020)
Table 20. North America Antifungal Drug Sales by Country (2015-2020) (K Units)
Table 21. North America Antifungal Drug Sales Market Share by Country (2015-2020)
Table 22. North America Antifungal Drug Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Antifungal Drug Revenue Market Share by Country (2015-2020)
Table 24. Europe Antifungal Drug Sales by Country (2015-2020) (K Units)
Table 25. Europe Antifungal Drug Sales Market Share by Country (2015-2020)
Table 26. Europe Antifungal Drug Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Antifungal Drug Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Antifungal Drug Sales by Region (2015-2020) (K Units)
Table 29. Asia Pacific Antifungal Drug Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Antifungal Drug Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Antifungal Drug Revenue Market Share by Region (2015-2020)
Table 32. Latin America Antifungal Drug Sales by Country (2015-2020) (K Units)
Table 33. Latin America Antifungal Drug Sales Market Share by Country (2015-2020)
Table 34. Latin America Antifungal Drug Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Antifungal Drug Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Antifungal Drug Sales by Country (2015-2020) (K Units)
Table 37. Middle East and Africa Antifungal Drug Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Antifungal Drug Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Antifungal Drug Revenue Market Share by Country (2015-2020)
Table 40. Global Antifungal Drug Sales (K Units) by Type (2015-2020)
Table 41. Global Antifungal Drug Sales Share by Type (2015-2020)
Table 42. Global Antifungal Drug Revenue (Million US$) by Type (2015-2020)
Table 43. Global Antifungal Drug Revenue Share by Type (2015-2020)
Table 44. Global Antifungal Drug Price (USD/Unit) by Type (2015-2020)
Table 45. Global Antifungal Drug Sales (K Units) by Application (2015-2020)
Table 46. Global Antifungal Drug Sales Market Share by Application (2015-2020)
Table 47. Global Antifungal Drug Sales Growth Rate by Application (2015-2020)
Table 48. Asperqillus Antifungal Drug Corporation Information
Table 49. Asperqillus Description and Business Overview
Table 50. Asperqillus Antifungal Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 51. Asperqillus Main Product
Table 52. Asperqillus Recent Development
Table 53. Alternaria Antifungal Drug Corporation Information
Table 54. Alternaria Corporation Information
Table 55. Alternaria Antifungal Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 56. Alternaria Main Product
Table 57. Alternaria Recent Development
Table 58. Abbott Laboratories Antifungal Drug Corporation Information
Table 59. Abbott Laboratories Corporation Information
Table 60. Abbott Laboratories Antifungal Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 61. Abbott Laboratories Main Product
Table 62. Abbott Laboratories Recent Development
Table 63. Pfizer Antifungal Drug Corporation Information
Table 64. Pfizer Corporation Information
Table 65. Pfizer Antifungal Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 66. Pfizer Main Product
Table 67. Pfizer Recent Development
Table 68. Glaxosmithkline Antifungal Drug Corporation Information
Table 69. Glaxosmithkline Corporation Information
Table 70. Glaxosmithkline Antifungal Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 71. Glaxosmithkline Main Product
Table 72. Glaxosmithkline Recent Development
Table 73. Bayer Healthcare Antifungal Drug Corporation Information
Table 74. Bayer Healthcare Corporation Information
Table 75. Bayer Healthcare Antifungal Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. Bayer Healthcare Main Product
Table 77. Bayer Healthcare Recent Development
Table 78. Novartis Antifungal Drug Corporation Information
Table 79. Novartis Corporation Information
Table 80. Novartis Antifungal Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Novartis Main Product
Table 82. Novartis Recent Development
Table 83. Sanofi-Aventis Antifungal Drug Corporation Information
Table 84. Sanofi-Aventis Corporation Information
Table 85. Sanofi-Aventis Antifungal Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. Sanofi-Aventis Main Product
Table 87. Sanofi-Aventis Recent Development
Table 88. Merck & Co. Antifungal Drug Corporation Information
Table 89. Merck & Co. Corporation Information
Table 90. Merck & Co. Antifungal Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. Merck & Co. Main Product
Table 92. Merck & Co. Recent Development
Table 93. Kramer Laboratories Antifungal Drug Corporation Information
Table 94. Kramer Laboratories Corporation Information
Table 95. Kramer Laboratories Antifungal Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. Kramer Laboratories Main Product
Table 97. Kramer Laboratories Recent Development
Table 98. Enzon Pharmaceuticals Antifungal Drug Corporation Information
Table 99. Enzon Pharmaceuticals Corporation Information
Table 100. Enzon Pharmaceuticals Antifungal Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 101. Enzon Pharmaceuticals Main Product
Table 102. Enzon Pharmaceuticals Recent Development
Table 103. Gilead Antifungal Drug Corporation Information
Table 104. Gilead Corporation Information
Table 105. Gilead Antifungal Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 106. Gilead Main Product
Table 107. Gilead Recent Development
Table 108. Sales Base and Market Concentration Rate of Raw Material
Table 109. Key Suppliers of Raw Materials
Table 110. Antifungal Drug Distributors List
Table 111. Antifungal Drug Customers List
Table 112. Market Key Trends
Table 113. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 114. Key Challenges
Table 115. Global Antifungal Drug Sales (K Units) Forecast by Type (2021-2026)
Table 116. Global Antifungal Drug Sales Market Share Forecast by Type (2021-2026)
Table 117. Global Antifungal Drug Revenue (Million US$) Forecast by Type (2021-2026)
Table 118. Global Antifungal Drug Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 119. Global Antifungal Drug Sales (K Units) Forecast by Application (2021-2026)
Table 120. Global Antifungal Drug Revenue (Million US$) Forecast by Application (2021-2026)
Table 121. Global Antifungal Drug Sales (K Units) Forecast by Region (2021-2026)
Table 122. Global Antifungal Drug Sales Market Share Forecast by Region (2021-2026)
Table 123. Global Antifungal Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 124. Global Antifungal Drug Revenue Market Share Forecast by Region (2021-2026)
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Antifungal Drug
Figure 2. Global Antifungal Drug Sales Market Share by Type: 2020 VS 2026
Figure 3. Echinocandins Product Picture
Figure 4. Azoles Product Picture
Figure 5. Ployenes Product Picture
Figure 6. Allylamines Product Picture
Figure 7. Global Antifungal Drug Consumption Market Share by Application: 2020 VS 2026
Figure 8. Aspergillosis
Figure 9. Dermatophytosis
Figure 10. Candidiasis
Figure 11. Global Antifungal Drug Market Size 2015-2026 (US$ Million)
Figure 12. Global Antifungal Drug Sales Capacity (K Units) (2015-2026)
Figure 13. Global Antifungal Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Antifungal Drug Sales Share by Manufacturers in 2020
Figure 15. Global Antifungal Drug Revenue Share by Manufacturers in 2019
Figure 16. The Global 5 and 10 Largest Players: Market Share by Antifungal Drug Revenue in 2019
Figure 17. Antifungal Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 18. Global Antifungal Drug Sales Market Share by Region (2015-2020)
Figure 19. Global Antifungal Drug Sales Market Share by Region in 2019
Figure 20. Global Antifungal Drug Revenue Market Share by Region (2015-2020)
Figure 21. Global Antifungal Drug Revenue Market Share by Region in 2019
Figure 22. North America Antifungal Drug Sales Market Share by Country in 2019
Figure 23. North America Antifungal Drug Revenue Market Share by Country in 2019
Figure 24. U.S. Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
Figure 25. U.S. Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Canada Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
Figure 27. Canada Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 28. Europe Antifungal Drug Sales Market Share by Country in 2019
Figure 29. Europe Antifungal Drug Revenue Market Share by Country in 2019
Figure 30. Germany Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
Figure 31. Germany Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. France Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
Figure 33. France Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. U.K. Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.K. Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Italy Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
Figure 37. Italy Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Russia Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
Figure 39. Russia Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Asia Pacific Antifungal Drug Sales Market Share by Region in 2019
Figure 41. Asia Pacific Antifungal Drug Revenue Market Share by Region in 2019
Figure 42. China Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
Figure 43. China Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Japan Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
Figure 45. Japan Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. South Korea Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
Figure 47. South Korea Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. India Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
Figure 49. India Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Australia Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
Figure 51. Australia Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Taiwan Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
Figure 53. Taiwan Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Indonesia Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
Figure 55. Indonesia Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Thailand Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
Figure 57. Thailand Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Malaysia Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
Figure 59. Malaysia Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Philippines Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
Figure 61. Philippines Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Vietnam Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
Figure 63. Vietnam Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Latin America Antifungal Drug Sales Market Share by Country in 2019
Figure 65. Latin America Antifungal Drug Revenue Market Share by Country in 2019
Figure 66. Mexico Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
Figure 67. Mexico Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Brazil Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
Figure 69. Brazil Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Argentina Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Middle East and Africa Antifungal Drug Sales Market Share by Country in 2019
Figure 73. Middle East and Africa Antifungal Drug Revenue Market Share by Country in 2019
Figure 74. Turkey Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
Figure 75. Turkey Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Saudi Arabia Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
Figure 77. Saudi Arabia Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. U.A.E Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
Figure 79. U.A.E Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Sales Market Share of Antifungal Drug by Type (2015-2020)
Figure 81. Sales Market Share of Antifungal Drug by Type in 2019
Figure 82. Revenue Share of Antifungal Drug by Type (2015-2020)
Figure 83. Revenue Market Share of Antifungal Drug by Type in 2019
Figure 84. Global Antifungal Drug Sales Growth by Type (2015-2020) (K Units)
Figure 85. Global Antifungal Drug Sales Market Share by Application (2015-2020)
Figure 86. Global Antifungal Drug Sales Market Share by Application in 2019
Figure 87. Global Revenue Share of Antifungal Drug by Application (2015-2020)
Figure 88. Global Revenue Share of Antifungal Drug by Application in 2020
Figure 89. Asperqillus Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Alternaria Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Glaxosmithkline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Bayer Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Sanofi-Aventis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Merck & Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Kramer Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Enzon Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Gilead Total Revenue (US$ Million): 2019 Compared with 2018
Figure 101. Price Trend of Key Raw Materials
Figure 102. Manufacturing Cost Structure of Antifungal Drug
Figure 103. Manufacturing Process Analysis of Antifungal Drug
Figure 104. Antifungal Drug Industrial Chain Analysis
Figure 105. Channels of Distribution
Figure 106. Distributors Profiles
Figure 107. Porter's Five Forces Analysis
Figure 108. North America Antifungal Drug Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 109. North America Antifungal Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 110. Europe Antifungal Drug Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 111. Europe Antifungal Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 112. Latin America Antifungal Drug Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 113. Latin America Antifungal Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 114. Middle East and Africa Antifungal Drug Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 115. Middle East and Africa Antifungal Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 116. Asia Pacific Antifungal Drug Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 117. Asia Pacific Antifungal Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 118. Bottom-up and Top-down Approaches for This Report
Figure 119. Data Triangulation
Figure 120. Key Executives Interviewed